Cooper Companies Inc (NYSE:COO) has been assigned a consensus recommendation of “Buy” from the eleven research firms that are presently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $272.29.
A number of research firms recently issued reports on COO. Zacks Investment Research raised Cooper Companies from a “sell” rating to a “hold” rating in a research report on Monday, October 1st. ValuEngine upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Thursday, September 27th. Raymond James lifted their price target on Cooper Companies from $270.00 to $300.00 and gave the stock an “outperform” rating in a report on Friday, September 21st. BMO Capital Markets lifted their price target on Cooper Companies from $280.00 to $285.00 and gave the stock an “outperform” rating in a report on Friday, August 31st. Finally, Oppenheimer set a $270.00 price target on Cooper Companies and gave the stock a “hold” rating in a report on Friday, August 31st.
In other news, Director Robert S. Weiss sold 58,543 shares of the business’s stock in a transaction that occurred on Wednesday, September 5th. The stock was sold at an average price of $252.82, for a total transaction of $14,800,841.26. Following the completion of the sale, the director now owns 157,710 shares in the company, valued at $39,872,242.20. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Allan E. Rubenstein sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $265.37, for a total value of $398,055.00. Following the sale, the director now owns 3,068 shares of the company’s stock, valued at approximately $814,155.16. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 80,809 shares of company stock valued at $20,740,667. Corporate insiders own 1.60% of the company’s stock.
Several large investors have recently modified their holdings of the company. LPL Financial LLC boosted its stake in shares of Cooper Companies by 15.1% in the first quarter. LPL Financial LLC now owns 5,354 shares of the medical device company’s stock valued at $1,225,000 after buying an additional 701 shares during the period. Allianz Asset Management GmbH boosted its stake in shares of Cooper Companies by 36.5% in the first quarter. Allianz Asset Management GmbH now owns 202,613 shares of the medical device company’s stock valued at $46,359,000 after buying an additional 54,143 shares during the period. Suntrust Banks Inc. boosted its stake in shares of Cooper Companies by 30.4% in the first quarter. Suntrust Banks Inc. now owns 2,667 shares of the medical device company’s stock valued at $609,000 after buying an additional 621 shares during the period. Brown Advisory Inc. boosted its stake in shares of Cooper Companies by 17.7% in the first quarter. Brown Advisory Inc. now owns 8,896 shares of the medical device company’s stock valued at $2,036,000 after buying an additional 1,338 shares during the period. Finally, IFM Investors Pty Ltd boosted its stake in shares of Cooper Companies by 86.5% in the second quarter. IFM Investors Pty Ltd now owns 1,699 shares of the medical device company’s stock valued at $400,000 after buying an additional 788 shares during the period. Institutional investors own 97.07% of the company’s stock.
Shares of NYSE:COO traded down $5.18 during midday trading on Monday, reaching $258.25. The company had a trading volume of 315,148 shares, compared to its average volume of 399,668. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58. The company has a market cap of $12.94 billion, a P/E ratio of 26.62, a P/E/G ratio of 2.00 and a beta of 0.75. Cooper Companies has a 1-year low of $216.47 and a 1-year high of $280.10.
Cooper Companies (NYSE:COO) last released its earnings results on Thursday, August 30th. The medical device company reported $3.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.07 by ($0.07). The company had revenue of $660.00 million during the quarter, compared to analyst estimates of $653.44 million. Cooper Companies had a net margin of 5.23% and a return on equity of 17.53%. As a group, equities analysts predict that Cooper Companies will post 11.62 earnings per share for the current fiscal year.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
See Also: How Do You Calculate Return on Equity (ROE)?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.